A single-dose membrane-anchored F1/LcrV mRNA vaccine confers protection against pneumonic plague: a preclinical study
eBioMedicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
A single-dose membrane-anchored F1/LcrV mRNA vaccine confers protection against pneumonic plague: a preclinical study. // eBioMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2352396426004391?dgcid=rss_sd_all
A single-dose membrane-anchored F1/LcrV mRNA vaccine confers protection against pneumonic plague: a preclinical study. eBioMedicine. https://www.sciencedirect.com/science/article/pii/S2352396426004391?dgcid=rss_sd_all
“A single-dose membrane-anchored F1/LcrV mRNA vaccine confers protection against pneumonic plague: a preclinical study.” eBioMedicine.
@article{article107400,
title = {A single-dose membrane-anchored F1/LcrV mRNA vaccine confers protection against pneumonic plague: a preclinical study},
journal = {eBioMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2352396426004391?dgcid=rss_sd_all}
}